1 Updates

American Clinical Solutions Releases Study "Alprazolam- Used and Abused"

Sep 3 2013, 5:14pm CDT | by PR.com

American Clinical Solutions provides testing service for alprazolam and alphahydroxy alprazolam in urine and oral fluid.

Sun City Center, FL, September 03, 2013 --(PR.com)-- Alprazolam (Xanax) is a short-acting benzodiazepine commonly prescribed for treating panic disorder, anxiety and insomnia. As a benzodiazepine,...

Filed under: news

Full Story below YouTube Videos

 
 

 

32 weeks ago

American Clinical Solutions Releases Study "Alprazolam- Used and Abused"

Sep 3 2013, 5:14pm CDT | by PR.com

American Clinical Solutions provides testing service for alprazolam and alphahydroxy alprazolam in urine and oral fluid.

Sun City Center, FL, September 03, 2013 --(PR.com)-- Alprazolam (Xanax) is a short-acting benzodiazepine commonly prescribed for treating panic disorder, anxiety and insomnia. As a benzodiazepine, alprazolam exerts its pharmacological actions by binding to the GABAA receptor in the central nervous system and potentiating its neuroinhibitory effects. Oral alprazolam is extensively metabolized by the human hepatic CYP3A4 to form two less active metabolites, alphahydroxy alprazolam and 4-hydroxyalprazolam. CYP3A4 is the most abundant P450 enzyme in both the human liver and intestine. While variations in metabolic capacity, due to CYP3A4 gene polymorphism, are rare, drug-drug interactions leading to induced or inhibited CYP3A4 enzymatic activities are quite common. Concurrent uses of grapefruit juice or drugs like macrolides and azoles might inadvertently increase alprazolam blood concentration and slow its clearance. Alprazolam and its metabolites are predominantly eliminated through the urinary route. American Clinical Solutions provides testing service for alprazolam and alphahydroxy alprazolam in urine and oral fluid. Detection windows for alprazolam and alphahydroxy alprazolam in urine are about 1-3 days after last exposure. In oral fluid, alprazolam can be detected within 12 hours. For unknown reasons, alprahydroxy alprazolam has been rarely detected in oral fluid. Early research indicated that in urine about 20% of a dose is eliminated as an unchanged drug, and excretion of alphahydroxy alprazolam accounts for 17% of a dose. An internal study conducted by American Clinical Solutions with patients prescribed alprazolam confirmed those findings. Average concentrations of positive (above cutoff value, 50 ng/ml for both) alprazolam and alphahydroxy alprazolam samples were 335 and 447 ng/ml. Detection rate of alphaphydroxy alprazolam was slightly higher than that of alprazolam among patients with the prescription (57.0% versus 49.7%).

Comparable urinary concentration and detection rates between alprazolam and its metabolite suggest that physicians prescribing alprazolam should expect to see both in a patient’s urine sample. A recent national survey suggested that alprazolam is the most commonly abused benzodiazepine [1]. In 2011, there were 123,744 emergency department (ED) visits due to nonmedical use of alprazolam nationwide, which accounted for 9.9% of all ED visits due to nonmedical use of medications [1] . The true number of alprazolam misuses in the general population might be even higher. The high prevalence of alprazolam misuses and abuses might be due to its pharmacological properties (as a drug with rapid onset of action), easy availability and a false sense of drug safety. Compared to other compounds like alcohol and barbiturates working on GABAA receptors, benzodiazepines are generally considered to have a higher margin of safety. Theoretically, benzodiazepines have a ceiling effect in GABAA-mediated pharmacological actions, and further increasing doses will not lead to heightened CNS depression. Among benzodiazepines, short-acting ones like alprazolam are deemed safer than long-acting ones like diazepam, simply due to their shorter half-lives in the human body. However, concomitant use of alprazolam, with other CNS depressants such as alcohol and opioid analgesics, could have an additive CNS depression effect and lead to severe toxicity or even death. In light of rampant alprazolam misuses and abuses, monitoring alprazolam adherence would be highly advisable for physicians to practice safe and effective medicine.

1. The Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. 2012.

Cheng Fang, MD., PH D., DABT | cheng.fang@americanclinicalsolutions.com
721 Cortaro Dr, Sun City Center, FL 33573 | T 866-762-8379 | F 813-634-4538

2012 American Clinical Solutions, LLC. All Rights Reserved

Contact Information:
American Clinical Solutions
Lauren Marshall
813-613-4533
Contact via Email
www.acslabtest.com

Read the full story here: http://www.pr.com/press-release/512482

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

White House updating online privacy policy
A new Obama administration privacy policy released Friday explains how the government will gather the user data of online visitors to WhiteHouse.gov, mobile apps and social media sites, and it clarifies that online...
 
 
LawTech Europe Congress Announces E-Discovery Expert Jason R. Baron as a Keynote Speaker for its 2014 Event in Prague
LawTech Europe Congress is pleased to have Jason R. Baron as a Keynote Speaker for its 2014 event. Jason is an internationally recognized speaker and author on the preservation of electronic documents and will add substantial value to this conference on digital evidence, computer forensics, cyber security, and legal technology.
 
 
French Retail, Éditions Atlas Uses Fiorano SOA for Real-Time Enablement of Its Global Operations
London, United Kingdom, April 18, 2014 --(PR.com)-- Fiorano Software today announced that Éditions Atlas, a leading French retail company has deployed the Fiorano SOA platform to integrate applications across...
 
 
Lucintel Anticipates Global Flat Glass Industry to Reach $66.6 Billion by 2019
Irving, TX, April 18, 2014 --(PR.com)-- The global flat glass industry is expected to reach an estimated $66.6 billion by 2019. The major drivers of flat glass are growth in automotive and construction industries....
 
 
 

Latest from the Network

White House updating online privacy policy
A new Obama administration privacy policy released Friday explains how the government will gather the user data of online visitors to WhiteHouse.gov, mobile apps and social media sites, and it clarifies that online...
Read more on Business Balla
 
LawTech Europe Congress Announces E-Discovery Expert Jason R. Baron as a Keynote Speaker for its 2014 Event in Prague
Prague, Czech Republic, April 18, 2014 --(PR.com)-- Jason R. Baron, Esq. is Of Counsel in the law firm of Drinker, Biddle & Reath, in Washington, D.C. As an internationally recognized speaker and author on the...
Read more on Business Balla
 
Lucintel Anticipates Global Flat Glass Industry to Reach $66.6 Billion by 2019
Irving, TX, April 18, 2014 --(PR.com)-- The global flat glass industry is expected to reach an estimated $66.6 billion by 2019. The major drivers of flat glass are growth in automotive and construction industries....
Read more on Business Balla
 
Lucideon to Talk at the EAUC Annual Conference 2014
Stoke-on-Trent, United Kingdom, April 18, 2014 --(PR.com)-- Ann-Marie Cornall, Sales Consultant – Assurance and representative of the EAUC Member’s Advisory Council, will be running the exchange session...
Read more on Business Balla
 
Vietnamese Member of Russell Bedford International Rebrands as Russell Bedford KTC
London, United Kingdom, April 18, 2014 --(PR.com)-- In line with a move towards greater use of global branding by firms in the Russell Bedford accounting network, KTC Audit & Business Advisory Co., Ltd., Russell...
Read more on Business Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla